The EML4-ALK fusion transcript occurs in 3 ~ 7% of all NSCLC cases, and these individuals were distinct from those harboring mutations in the EGFR gene [155, 161–163]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.